Subfractions of high-density lipoprotein cholesterol during estrogen replacement therapy: A comparison between progestogens and natural progesterone
- 1 March 1985
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 151 (6), 746-750
- https://doi.org/10.1016/0002-9378(85)90509-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administrationBJOG: An International Journal of Obstetrics and Gynaecology, 1984
- Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium.BMJ, 1983
- Percutaneous oestrogen therapy opposed by lynestrenol or natural progesterone - effects on circulating oestrogens, FSH, sex hormone binding globulin and pregnancy zone proteinMaturitas, 1983
- A comparison of liver protein induction in postmenopausal women during oral and percutaneous oestrogen replacement therapyBJOG: An International Journal of Obstetrics and Gynaecology, 1983
- Influence of Esterified Estrogens and Medroxyprogesterone on Lipid Metabolism and Sex SteroidsHormone and Metabolic Research, 1982
- Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogensMaturitas, 1982
- Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.BMJ, 1981
- MENOPAUSAL OESTROGEN THERAPY AND PROTECTION FROM DEATH FROM ISCHAEMIC HEART DISEASEThe Lancet, 1981
- Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement TherapyNew England Journal of Medicine, 1981
- Absorption and metabolism of oral progesterone.BMJ, 1980